Capricor Therapeutics (CAPR) Misses Q1 EPS by 2c

Capricor Therapeutics (NASDAQ: CAPR) reported Q1 EPS of ($0.14), $0.02 worse than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Capricor Therapeutics (CAPR) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• John Wiley & Sons, Inc. (WLY) Tops Q4 EPS by 12c; offers outlook